The chemical class known as Veli3 inhibitors encompasses a diverse range of compounds, each designed to target various pathways and processes integral to the function of Veli3. Veli3, a protein involved in crucial cellular mechanisms such as cell polarity, synaptic assembly, and signal transduction, serves as a key intersection point in numerous cellular activities. The inhibitors in this class are characterized by their ability to modulate the activity of Veli3 through different mechanistic approaches. One primary method through which these inhibitors can impact Veli3 involves targeting the cell polarity pathways. Since Veli3 plays a significant role in maintaining the apical-basal polarity of epithelial cells, compounds that disrupt the signaling pathways governing cell polarity can have a consequential influence on Veli3's function. By altering the dynamics of cell polarity pathways, these inhibitors can affect Veli3's capacity to maintain cellular structure and function, which is pivotal in tissue organization and integrity.
Another vital aspect of Veli3 function is its role in synaptic function within the nervous system. Inhibitors that act on neurotransmitter receptors or synaptic signaling pathways present a method to modulate Veli3's involvement in these processes. Such compounds can influence the synaptic localization of proteins and synaptic strength, indirectly impacting Veli3's contribution to neuronal communication and plasticity. Additionally, Veli3's participation in various signal transduction pathways offers another target for inhibition. Compounds that interact with key signaling molecules and receptors with which Veli3 associates can modify the downstream effects of these pathways. This modification can, in turn, influence the processes regulated by Veli3, such as cell growth, survival, and differentiation. The ability of these inhibitors to influence Veli3 through diverse mechanisms highlights the complexity of cellular regulation and the interconnected nature of Veli3's role within these processes. In conclusion, Veli3 inhibitors represent a significant category of compounds in the exploration of cellular functionality. Their diverse mechanisms of action underscore the intricate network of interactions and pathways in which Veli3 is involved. By modulating Veli3 activity through various pathways, these inhibitors provide a multifaceted approach to influencing critical cellular functions. As research in this area advances, the understanding of Veli3's role in cell polarity, synaptic function, and signal transduction continues to evolve, further emphasizing the importance of these inhibitors in investigating the complex landscape of cellular regulation and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
IWP-2, an inhibitor of Wnt production, could possibly inhibit Veli3 by affecting its role in cell polarity and tight junction formation. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $204.00 | 2 | |
CNQX, an AMPA receptor antagonist, could possibly inhibit Veli3 by influencing its synaptic functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, could possibly inhibit Veli3 by impacting its role in signal transduction pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, could possibly inhibit Veli3 in cellular growth and survival pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride, a GSK-3 inhibitor, could possibly inhibit Veli3 by affecting its involvement in cell polarity and synaptic function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, a MEK inhibitor, could possibly inhibit Veli3's role in the MAPK/ERK pathway and cell signaling. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine, a calcium channel blocker, could possibly inhibit Veli3's role in synaptic transmission. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib, a Src family tyrosine kinase inhibitor, could possibly inhibit Veli3's signal transduction roles. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, could possibly inhibit Veli3 in cellular stress response pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082, an NF-kB inhibitor, could possibly inhibit Veli3's role in cell survival and inflammatory response. | ||||||